Genelux CorporationGNLXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P36
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -0.36% |
| Q2 2025 | 1.28% |
| Q1 2025 | -27.94% |
| Q4 2024 | 60.95% |
| Q3 2024 | -8.29% |
| Q2 2024 | 10.15% |
| Q1 2024 | -3.61% |
| Q4 2023 | 47.57% |
| Q3 2023 | -4.21% |
| Q2 2023 | 3.44% |
| Q1 2023 | 15.28% |
| Q4 2022 | 2.24% |
| Q3 2022 | 32.13% |
| Q2 2022 | -22.88% |
| Q1 2022 | 42.88% |
| Q4 2021 | 14.42% |
| Q3 2021 | -5.85% |
| Q2 2021 | -8.01% |
| Q1 2021 | 7.47% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | -1.16% |
| Q1 2020 | 0.00% |